Biomaterials | Research Interests

Name	Email	PhD Program
Perry, Jillian WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Pharmaceutical Sciences RESEARCH INTEREST Biomaterials, Drug Delivery, Immunology, Nanomedicine, Translational Medicine	Our lab is broadly interested in utilizing high resolution 3D printing to develop novel drug delivery carriers for the treatment of cancer and infectious diseases. Current research interests lay in manufacturing biodegradable porous hydrogel scaffold implants for cell/drug delivery for the treatment of recurrent brain cancer. We are actively investigating biomaterial properties for passive cell/drug loading into scaffolds as well as developing materials and methods to support conjugation strategies for actuated release mechanisms.
Nazockdast, Ehssan WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Applied Physical Sciences RESEARCH INTEREST Biomaterials, Biophysics, Cell Biology, Computational Biology	We are interested in the physics of soft and squishy materials, especially the organization and mechanics of living cellular materials. We use theory and simulation in close collaboration with experiments to understand the complex structural and mechanical behavior of these systems. These questions and our approach to them are interdisciplinary and intersect several traditional fields, including cell biology, biophysics, fluid dynamics and applied mathematics.
Freeman, Ronit WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Applied Physical Sciences, Biomedical Engineering, Chemistry RESEARCH INTEREST Biomaterials, Biophysics, Cancer Biology, Cell Biology, Cell Signaling, Drug Delivery, Drug Discovery, Nanomedicine, Translational Medicine	My lab focuses on developing bioinspired molecular constructs and material platforms that can mimic proteins and be programmed to respond to stimuli resulting from biomolecular recognition. Major efforts are directed to design peptide- and nucleic acid-based scaffolds or injectable nanostructures to create artificial extracellular matrices that can directly signal cells.
Superfine, Richard WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Applied Physical Sciences, Biomedical Engineering RESEARCH INTEREST Biomaterials, Biophysics, Cell Biology, Computational Biology, Systems Biology	Superfine’s group studies stimulus-responsive active and living materials from the scale of individual molecules to physiological tissues, including DNA, cells and microfluidic-based tissue models. We develop new techniques using advanced optical, scanning probe, and magnetic force microscopy. We pursue diverse physiological phenomena from cancer to immunology to mucus clearance in the lung. Our work includes developing systems that mimic biology, most recently in the form of engineered cilia arrays that mimic lung tissue while providing unique solutions in biomedical devices.
Bai, Wubin WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Biomedical Engineering RESEARCH INTEREST Biomaterials, Biophysics, Drug Delivery	Our research focuses on both fundamental and applied study of soft materials and nanomaterials, develop fabrication approaches to enable hybrid integration of multi-materials towards high-performance electronic and photonic systems, innovate new technology that can intelligently immerse electronics and photonics into biological systems, and create new tools and devices to address unmet clinical needs and improve human healthcare. Our lab fosters a collaborative environment that converges expertise/interests from various backgrounds including materials science and engineering, electrical engineering, physics, chemical engineering, mechanical engineering, and biomedical engineering. We provide hands-on learning, enjoy making practical tools, and aspire to transform scientific advancements into societal solutions.
Fenton, Owen EMAIL PUBLICATIONS	PHD PROGRAM Pharmaceutical Sciences RESEARCH INTEREST Biomaterials, Drug Delivery, Drug Discovery, Nanomedicine, Translational Medicine	The broad aim of research in the Fenton Laboratory is to develop and evaluate synthetic drug delivery platforms to treat neurodegenerative disorders in the brain using RNA therapeutics. RNA therapeutics represent a particularly promising class of therapeutics for neurodegenerative management given their ability to tune levels of specific protein expression in living systems. For example, protein downregulation can be achieved by administering short interfering RNAs (siRNAs); alternatively, proteins can be upregulated by messenger RNA (mRNA) administration. Despite this promise, fewer than 0.05% of the world’s clinically approved drugs are RNA therapeutics, and their translation to neurodegenerative disorders in the brain warrants further study at the fundamental and clinical levels. To address these challenges, our group focuses on the discovery and development of molecular carriers and technology platforms to improve the targeting, safety, and efficacy of RNA drugs within target cells. Specifically, our group leverages an interdisciplinary approach to develop lipid nanoparticles (LNP) as well as soft matter hydrogel platforms that can serve as carrier systems and/or drug delivery models for RNA drugs. Further, our group also explores the development of technological platforms to further expand the potential of RNA drugs within resource limited settings. Lastly, given that mRNA drugs can be engineered to encode for virtually any polypeptide or protein based antigen, our group also aims to leverage our platformable LNP technologies for the study and prevention of cancers and infectious disease. In undertaking such an approach, the goal of our research is to equip students with fundamental skillsets for the development of next generation drugs while simultaneously developing clinically-relevant carrier platforms and technologies for the study, prevention, and treatment of human disease.
Benhabbour, Rahima WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Pathobiology & Translational Science RESEARCH INTEREST Biomaterials, Drug Delivery, Nanomedicine, Pharmacology	Dr. Benhabbour’s academic research focuses on development of novel tunable delivery platforms and polymer-based devices to treat or prevent a disease. Her work combines the elegance of organic and polymer chemistry with the versatility of engineering and formulation development to design and fabricate efficient and translatable nanocarriers and drug delivery systems for cancer treatment and HIV prevention. Dr. Benhabbour has also Founded her startup company Anelleo, Inc. (AnelleO) in 2016 to develop the first 3D printed intravaginal ring as a platform technology for women’s health. Current technologies in development in Dr. Benhabbour’s Lab include: – 3D Printed intravaginal ring technology: A) Multipurpose prevention technology (MPT) for prevention of HIV/STIs and unplanned pregnancy. – Polymer based ultra-long-acting injectable implant for HIV prevention and treatment. – Combinatory chitosan/cellulose nanocrystals thermoresponsive hydrogel system: A) Sub-Q or intraosseous injectable for treatment of osteoporosis; B) Bio-ink for 3D bioprinting; C) Scaffold for stem cell delivery (e.g. iNSCs for treatment of post-surgical glioblastoma. – Mucoadhesive thin film for treatment of vulvodynia. – Targeted nanoparticles and hydrogel scaffolds for treatment of NSCLC.
Lu, Zhiyue WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Chemistry RESEARCH INTEREST Biomaterials, Biophysics, Cell Signaling, Computational Biology, Drug Delivery, Systems Biology
Button, Brian WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Biochemistry & Biophysics RESEARCH INTEREST Biochemistry, Biomaterials, Biophysics, Cell Biology, Cell Signaling, Drug Delivery, Drug Discovery, Nanomedicine, Pathology, Physiology, Systems Biology, Translational Medicine	The Button lab in the Department of Biochemistry and Biophysics is part of the Marsico Lung Institute. Our lab is actively involved in projects that are designed to define the pathogenesis of muco-obstructive pulmonary disorders and to identify therapies that could be used to improve the quality of life in persons afflicted by these diseases. In particular, our research works to understand the biochemical and biophysical properties of mucin biopolymers, which give airway mucus its characteristic gel-like properties, and how they are altered in diseases such as Asthma, COPD, and cystic fibrosis.
Nguyen, Juliane WEBSITE EMAIL PUBLICATIONS	PHD PROGRAM Pharmaceutical Sciences RESEARCH INTEREST Biochemistry, Bioinformatics, Biomaterials, Drug Delivery, Immunology, Translational Medicine	The Nguyen lab develops the next generation of effective and safe biotherapeutics for life-threatening diseases such as cancer and myocardial infarction. We engineer novel immunomodulatory carriers based on genetically encoded materials and lipids that home to the site of disease, respond to changes in the microenvironment, and effectively deliver nucleic acids and drugs.

Research Interest: Biomaterials